Cases Of CRE Not As Common In US Children As ESBL-E, Study Finds

Healio (6/4, Weldon) reports, “Cases of carbapenem-resistant Enterobacterales, or CRE, were not as common in U.S. children as cases of extended-spectrum beta-lactamase-producing Enterobacterales, or ESBL-E, according to a study published in Emerging Infectious Diseases.” In the study, researchers found “an overall annual CRE incidence rate of 0.7 per 100,000 population during the 5-year period.” This compares to “an overall annual ESBL-E incidence rate of 23.08 per 100,000 population.”